BE621398A - - Google Patents
Info
- Publication number
- BE621398A BE621398A BE621398DA BE621398A BE 621398 A BE621398 A BE 621398A BE 621398D A BE621398D A BE 621398DA BE 621398 A BE621398 A BE 621398A
- Authority
- BE
- Belgium
- Prior art keywords
- sugar
- viruses
- cores
- candy
- desc
- Prior art date
Links
- 235000009508 confectionery Nutrition 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 241000991587 Enterovirus C Species 0.000 description 9
- 208000000474 Poliomyelitis Diseases 0.000 description 8
- 229960005486 vaccines Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 230000002238 attenuated Effects 0.000 description 5
- 241000274177 Juniperus sabina Species 0.000 description 4
- 210000004940 Nucleus Anatomy 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- HDAJUGGARUFROU-UHFFFAOYSA-L ({5-amino-7,13,13-trioxo-17-oxa-12,14-dithia-2,4,6,9-tetraaza-13-molybdatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-3(8),4,11(15)-trien-16-yl}methoxy)phosphonic acid Chemical compound O=[Mo+2]=O.N1C(C(=C([S-])C(COP(O)(O)=O)O2)[S-])C2NC2=C1C(=O)N=C(N)N2 HDAJUGGARUFROU-UHFFFAOYSA-L 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N Alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282619 Hylobates lar Species 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 208000003926 Myelitis Diseases 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 229940035295 Ting Drugs 0.000 description 1
- 241001459538 Ute Species 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 125000003607 serino group Chemical class [H]OC(=O)C([H])(N([H])*)C([H])([H])O[H] 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE621398A true BE621398A (de) | 1900-01-01 |
Family
ID=194439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE621398D BE621398A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE621398A (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A2 (de) * | 1989-09-29 | 1991-04-03 | The Nisshin Oil Mills, Ltd. | Stabile immunogene Zusammensetzung |
| EP0603992A1 (de) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen |
-
0
- BE BE621398D patent/BE621398A/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0420785A2 (de) * | 1989-09-29 | 1991-04-03 | The Nisshin Oil Mills, Ltd. | Stabile immunogene Zusammensetzung |
| EP0420785A3 (en) * | 1989-09-29 | 1991-07-31 | Nisshin Oil Mills Ltd | Stable immunogen composition |
| US5176909A (en) * | 1989-09-29 | 1993-01-05 | The Nisshin Oil Mills, Ltd. | Stable immunogen composition for oral administration |
| US5591433A (en) * | 1991-06-21 | 1997-01-07 | University Of Cincinnati | Oral administration of immunologically active biomolecules and other therapeutic proteins |
| EP0603992A1 (de) * | 1992-12-22 | 1994-06-29 | University Of Cincinnati | Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen |
| EP0603992B1 (de) * | 1992-12-22 | 1996-10-09 | University Of Cincinnati | Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6616431B2 (ja) | マイクロバイオータ回復治療（ｍｒｔ）組成物の製造方法 | |
| US10828340B2 (en) | Microbiota restoration therapy (MRT) compositions and methods of manufacture | |
| NO142866B (no) | Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav | |
| JPS58113124A (ja) | 固体成形品 | |
| MX2008014398A (es) | Formulacion de vacuna de nicotina-portador. | |
| WO2019241523A1 (en) | Microbiota restoration therapy (mrt) compositions and methods of manufacture | |
| BE621398A (de) | ||
| CN114053343A (zh) | 一种中药组合物、制备方法及应用 | |
| Zain et al. | Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards | |
| Pu et al. | Salting-Out crystallization of glycopeptide Vancomycin: Phase behavior study to control the crystal habit | |
| ES2314772T3 (es) | Composicion para la prevencion y tratamiento de afecciones catarrales. | |
| US9616125B2 (en) | Stable nocathiacin lyophilized injection agent | |
| Pardeshi et al. | Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review | |
| TW200526268A (en) | Injectable composition | |
| RU2225709C2 (ru) | Лиофилизат с улучшенной восстанавливаемостью в исходное состояние (варианты), способ его получения и фармацевтический препарат | |
| CN107011419A (zh) | 具有抗病毒活性的板蓝根活性糖肽及其制备方法与应用 | |
| BE1005589A3 (fr) | Medicament pour le traitement de la dermatite. | |
| KR102540346B1 (ko) | 꿀벌 유인용 조성물 및 이를 포함하는 양봉용 약물 전달 시스템 | |
| CN105997868B (zh) | 一种达比加群酯纳米混合胶束及其制备方法 | |
| FR2479690A1 (fr) | Medicament utile notamment pour le traitement de l'arthrite et son procede d'obtention par extraction des feuilles et rhizomes de polypodiaceae | |
| CN107998111A (zh) | DAS在制备预防/或治疗LPS/D-GalN诱导的急性免疫性肝损伤药物中的应用 | |
| CN113288943A (zh) | 一种中药组合物在制备治疗或预防冠状病毒感染的药物中的应用 | |
| WO2020143333A1 (zh) | 蒲公英甾酮在制备防治老年痴呆的药物中的应用 | |
| Kumar et al. | Solid dispersion techniques: a review | |
| KR101731065B1 (ko) | 독성 및 항당뇨 효능이 개선된 신규한 함초 추출물의 제조 방법 및 이 함초 추출물을 함유하는 조성물 |